Lv0
0 积分 2024-11-10 加入
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
20小时前
已完结
Ertugliflozin and Slope of Chronic eGFR
20小时前
已完结
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice
20小时前
已完结
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice
20小时前
已完结
The effect of dapagliflozin on renal function in patients with type 2 diabetes
1天前
已完结
SGLT2 inhibitors reduce adverse kidney and cardiovascular events in patients with advanced diabetic kidney disease: A population-based propensity score-matched cohort study
1天前
已完结
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
1天前
已完结
Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?
1天前
已完结
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
1天前
已完结
Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence
1天前
已完结
皖公网安备34019202002308
